Peter Garcia
2017 - PDL BioPharma
In 2017, Peter Garcia earned a total compensation of $1.4M as Vice President and Chief Financial Officer at PDL BioPharma, a 10% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $463,443 |
|---|---|
| Salary | $430,301 |
| Stock Awards | $433,845 |
| Other | $58,000 |
| Total | $1,385,589 |
Garcia received $463.4K in non-equity incentive plan, accounting for 33% of the total pay in 2017.
Garcia also received $430.3K in salary, $433.8K in stock awards and $58K in other compensation.
Rankings
In 2017, Peter Garcia's compensation ranked 7,380th out of 14,666 executives tracked by ExecPay. In other words, Garcia earned more than 49.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,380 out of 14,666 | 50th |
Division Manufacturing | 2,750 out of 5,772 | 52nd |
Major group Chemicals And Allied Products | 893 out of 2,075 | 57th |
Industry group Drugs | 699 out of 1,731 | 60th |
Industry Biological Products, Except Diagnostic Substances | 132 out of 313 | 58th |
Source: SEC filing on April 26, 2018.
Garcia's colleagues
We found five more compensation records of executives who worked with Peter Garcia at PDL BioPharma in 2017.
News
ALX ONCOLOGY HOLDINGS CEO Jason Lettmann receives $4.9M in 2023
April 22, 2024
ALX ONCOLOGY HOLDINGS CEO Jaume Pons' 2022 pay falls 63% to $3.7M
April 24, 2023
PDL BioPharma CEO Dominique Monnet's 2019 pay jumps 168% to $6.7M
July 7, 2020
PDL BioPharma CEO John McLaughlin's 2018 pay rises 20% to $4.1M
April 30, 2019